in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Strides Agrees on Injectables Deal
8:53 AM MST | November 7, 2007 | Chemical Week Editorial Staff
Pharmaceutical company Strides Arcolab (Bangalore, India) says it has agreed on a deal with pharma manufacturer Sagent Pharmaceuticals (Schaumburg, IL) to jointly develop, supply, and market injectable products for the U.S. market. Strides Arcolab will develop and supply injectable products that Sagent will market in the U.S., under terms of the deal. The agreement will initially target 25 products, the companies say. Sagent is a privately held specialty pharma company that was founded in 2006. “The strength and experience of our sales organization as well...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee